Quick Answer
LakeShore Biopharma Co., Ltd. reported Stockholders Equity of $69.62 million for fiscal year 2025.
LakeShore Biopharma Co., Ltd. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $69.62M | -88.1% |
| 2024 | $585.21M | -19.7% |
| 2023 | $728.45M | +204.2% |
| 2022 | -$698.97M | -37.4% |
| 2021 | -$508.86M | +39.9% |
| 2020 | -$847.32M | — |
- LakeShore Biopharma Co., Ltd. showed a decrease of -88.1% in Stockholders Equity compared to the prior fiscal year.
- Over the 2020–2025 period, LakeShore Biopharma Co., Ltd.’s stockholders equity has grown by 108.2% (from -$847.32 million to $69.62 million).
- The most recent figure is from LakeShore Biopharma Co., Ltd.’s fiscal year 2025 report (Form 20-F), filed with the SEC on July 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: